Chiropractors in Lake Panasoffkee, FL Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Ms. Karrie Markland-papenheim, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 116 N C 470, Lake Panasoffkee, FL 33538 Phone: 352-793-3337 Fax: 352-793-3337 |
 Markland Chiropractic Clinic, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 116 N County Road 470, Lake Panasoffkee, FL 33538 Phone: 352-793-3337 Fax: 352-793-3337 |
News Archive
The Cryogenic Institute of New England, Inc. completes transition to new facility
The Cryogenic Institute of New England, Inc. is pleased to announce the completed transition to 78 Chilmark Street, Worcester, MA 01604. The new facility is located just off of Shrewsbury Street in Worcester. The new facility boasts nearly 5,000 square feet of total area, allowing the Cryogenic Institute to expand its operations.
Prominent buildings and landmarks nationwide to light up purple to honor premature babies
To honor the 1 in 10 babies in the United States born prematurely each year, prominent buildings and landmarks nationwide, including the Empire State Building in New York City, will be shining in purple light in November to observe Prematurity Awareness Month.
Data demonstrates possibility of measuring biomarkers relevant to autism in adult saliva
Future Science Group today announced the publication of a new article in Future Science OA, reporting data demonstrating the possibility of measuring 10 biomarkers relevant to autism spectrum disorder in adult saliva.
Soligenix closes previously announced registered public offering
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that on December 24, 2014 it closed its previously announced registered public offering.
Biocryst seeks FDA NDA approval for Peramivir to treat influenza
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
› Verified 5 days ago